Novartis Asks Court To Ban Generic MS Drug Pending Trial
Novartis AG asked a London court on Thursday to ban rival Teva Pharmaceuticals and three other drugmakers from selling any generic versions of a multiple sclerosis drug while the pharmaceutical giant...To view the full article, register now.
Already a subscriber? Click here to view full article